How the 2025 American Diabetes Association Guidelines Will Impact Your Pharmacy Benefit Strategy
By Jason Peterson, RPh; Beckie Fenrick, PharmD, MBA; and Emily Crisano, PharmD, RPh The American Diabetes Association (ADA) recently released […]
By Jason Peterson, RPh; Beckie Fenrick, PharmD, MBA; and Emily Crisano, PharmD, RPh The American Diabetes Association (ADA) recently released […]
Even the most seasoned brokers can overlook small details that make a big impact during RFP season. With timelines tightening
By Beckie Fenrick, PharmD, MBA; Emily Crisano, PharmD, RPh; and Jason Peterson, RPh Weight management isn’t just a personal issue—it’s
As cost-sharing increasingly shifts toward employees, employers are facing growing scrutiny over their pharmacy benefit strategies. Employees, frustrated by rising
By Beckie Fenrick, PharmD, MBA; Emily Crisano, PharmD, RPh; and Jason Peterson, RPh The first quarter of 2025 has brought
By Beckie Fenrick, PharmD, MBA; Emily Crisano, PharmD, RPh; and Jason Peterson, RPh The market for GLP-1 receptor agonists is
By Bethany Hruschak, Senior Manager, Pricing and Analytics Managing pharmacy costs is an essential but complex task for organizations striving